CHORD1 CHOlesterol Lowering and Residual Risk in Diabetes Type 1

Go Back to All Clinical Trials

CHORD1 CHOlesterol Lowering and Residual Risk in Diabetes Type 1

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Type 1 Diabetes
Age: Between 18 Year(s) - 89 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. LDL-C >100mg/dl.
2. Able and willing to provide written informed consent for the study.

You may not be eligible for this study if the following are true:

1. Established cardiovascular disease on antithrombotic therapy.
2. Triglycerides > 400mg/dl.
3. Use of a PCSK9 inhibitor.
4. Recent infection in the past 30 days.
5. Any hospitalization in the past 30 days.
6. Use of Immunosuppressive therapy.
7. Use of any antithrombotic therapy.
8. Use of aspirin.
9. Use of NSAID within the past 72 hours.
10. Pregnancy.
11. Anemia (hemoglobin < 9 g/dl) or thrombocytopenia (Platelet count < 75), or thrombocytosis (Platelet count > 600).
12. A history of non-traumatic severe bleeding or bleeding disorders.
13. Chronic kidney disease.
14. Type 2 Diabetes, monogenic diabetes syndromes, or diabetes in the context of disease of the exocrine pancreas (such as pancreatitis, trauma or pancreatectomy, neoplasia, cystic fibrosis, hemochromatosis).

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies